COVID-19 Alert Banner
-
Update to VMC access and services as of 5/18/20 -
Ryan Roberts, MD, PhD. -
Clinical Trials -
Clinical trials: Myths and misconceptions -
Cheryl London - TEDxOhioStateUniversity -
Clinical Trials in Veterinary Medicine
Blue Buffalo Veterinary Clinical Trials Office
- Phone (614) 247-8706
- Fax (614) 247-8428
- CVM-ClinicalTrials@osu.edu
Monday-Friday 8:00am to 5:00pm
New Trials
The goal of this study is to identify potential targets for developing vaccines to prevent dogs from developing skin infections induced by a common dog bacterium, Staphylococcus pseudintermedius (Staph).
This clinical trial evaluates the safety and efficacy of papaverine (PPV) as a method to reduce tumor hypoxia (low oxygen) in dogs with soft tissue sarcoma. Tumor hypoxia is a barrier to effective radiation therapy of solid tumors, so elimination of hypoxia will enhance effectiveness of radiation to treat cancerous tissue in dogs and humans.
The purpose of this study is to establish evidence of effectiveness of natural killer (NK) cells from healthy dogs given in combination with chemotherapy to dogs with bone tumors (osteosarcoma).
